Other OTC - Delayed Quote USD

Carl Zeiss Meditec AG (CZMWY)

106.40 -1.25 (-1.16%)
At close: April 25 at 3:45 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Markus Weber CEO & Chairman of Management Board 968.7k -- --
Mr. Justus Felix Wehmer CFO & Member of the Management Board 652k -- 1965
Dr. Christian Munster Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board -- -- 1971
Stefanie Spanagel Chief Operating Officer -- -- --
Mr. Sebastian Frericks Director of Investor Relations -- -- --
Eva-Maria Heine Chief Human Resources Officer -- -- --
Mr. Steven C. Schallhorn M.D. Chief Medical Officer for Global Ophthalmic Devices -- -- --
Mr. Andrew Chang Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc. -- -- --
Dr. Euan S. Thomson Ph.D. President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit -- -- 1963
Mr. Magnus Reibenspiess Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technology -- -- --

Carl Zeiss Meditec AG

Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Corporate Governance

Carl Zeiss Meditec AG’s ISS Governance QualityScore as of April 1, 2024 is 8. The pillar scores are Audit: 4; Board: 7; Shareholder Rights: 6; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 10, 2024
    Dividend Date
  • Mar 22, 2024
    Ex-Dividend Date

Upcoming Events

Related Tickers